Daniel S. Peeper

20082018
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2018

  • 18 Article
  • 4 Research external, graduation VU University Amsterdam
  • 3 Research VU University Amsterdam, graduation VU University Amsterdam

An Odyssey towards personalised medicine in breast cancer: From discovering new cancer genes to revealing drivers of therapeutic resistance

Ikink, G. J., 2018, 254 p.

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

Identifying molecular classifiers and therapeutic targets for poor-prognosis cancers

Iskit, S., 2018, 162 p.

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study

van der Hiel, B., Haanen, J. B. A. G., Stokkel, M. P. M., Peeper, D. S., Jimenez, C. R., Beijnen, J. H., van de Wiel, B. A., Boellaard, R., van den Eertwegh, A. J. M. & REPOSIT study group, 15 Sep 2017, In : BMC Cancer. 17, 1, p. 649

Research output: Contribution to journalArticleAcademicpeer-review

BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts

Kemper, K., Krijgsman, O., Kong, X., Cornelissen-Steijger, P., Shahrabi, A., Weeber, F., van der Velden, D. L., Bleijerveld, O. B., Kuilman, T., Kluin, R. J. C., Sun, C., Voest, E. E., Ju, Y. S., Schumacher, T. N. M., Altelaar, A. F. M., McDermott, U., Adams, D. J., Blank, C. U., Haanen, J. B. & Peeper, D. S., 28 Jun 2016, In : Cell Reports. 16, 1, p. 263-277

Research output: Contribution to journalArticleAcademicpeer-review

Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer

Iskit, S., Lieftink, C., Halonen, P., Shahrabi, A., Possik, P. A., Beijersbergen, R. L. & Peeper, D. S., 12 Jul 2016, In : Oncotarget. 7, 28, p. 42859-42872

Research output: Contribution to journalArticleAcademicpeer-review